Recombinant Xanthomonas oryzae pv. oryzae Queuine tRNA-ribosyltransferase (tgt)

What is Queuine tRNA-ribosyltransferase (tgt) and what is its function in Xanthomonas oryzae pv. oryzae?

Queuine tRNA-ribosyltransferase (tgt) is an enzyme (EC 2.4.2.29) that catalyzes the incorporation of queuine into tRNA through a unique base-for-base exchange reaction, replacing guanine with queuine in the anticodon loop of specific tRNAs. In prokaryotes like Xanthomonas oryzae pv. oryzae (Xoo), tgt plays a role in modifying tRNA molecules containing G34U35N36 sequences. The modification occurs at position 34 (the wobble position) of tRNAs for Asp, Asn, His, and Tyr. This post-transcriptional modification is believed to influence translational fidelity and efficiency, potentially impacting bacterial pathogenicity and cellular function .

How does bacterial tgt differ from eukaryotic tgt in structure and function?

Bacterial tgt and eukaryotic tgt differ in several key aspects:

• Substrate specificity: Bacterial tgt incorporates a precursor of queuine called preQ1, while eukaryotic tgt directly incorporates queuine.

• Enzyme composition: Bacterial tgt functions as a monomer, whereas eukaryotic tgt operates as a heterodimer composed of QTRT1 (catalytic subunit) and QTRT2 (accessory subunit) .

• Reaction reversibility: Queuine modification by eukaryotic tgt is an irreversible event, whereas some bacterial modifications can be reversible under certain conditions .

• Evolutionary conservation: Both share core catalytic domains but have diverged in terms of regulatory elements and auxiliary domains.

• Role in pathogenicity: In bacteria like Xoo, tgt-mediated modifications may influence virulence and host interactions differently than in eukaryotic systems.

What experimental approaches are used to assess tgt activity in vitro?

Several methodological approaches are employed to assess tgt activity in vitro:

• tRNA [14C] guanine displacement assay: This assay measures the ability of tgt to displace radiolabeled guanine from pre-charged tRNA. The displacement is quantified by separating tRNA from free nucleobases using DEAE-cellulose resin and subsequent scintillation counting .

• tRNA-[14C] guanine incorporation assay: This measures the ability of tgt to insert [14C] guanine into the anticodon loop of tRNA that has been previously modified with guanine, queuine, or other substrates .

• Mass spectrometry: MALDI-TOF or LC-MS/MS can be used to directly detect the modified nucleoside in tRNA digests.

• Spectrophotometric assays: Changes in absorbance can be used to monitor tgt activity in real-time.

• Fluorescence-based assays: Using fluorescently labeled substrates to track enzyme activity.

How can researchers optimize recombinant Xoo tgt expression and purification for structural studies?

Optimizing recombinant Xoo tgt expression and purification for structural studies requires careful consideration of several factors:

• Expression system selection:

  • For Xoo tgt, E. coli BL21(DE3) strains with tgt knockouts (tgt::Kmr) are preferred to prevent contamination with endogenous E. coli tgt .

  • Consider using controlled expression systems like pET with T7 promoter for high-yield protein production.

• Protein tagging strategy:

  • N-terminal polyhistidine tags facilitate purification while minimizing interference with enzymatic activity.

  • For eukaryotic tgt expressed in bacteria, co-expression of QTRT1 with N-terminal His-tag and QTRT2 with C-terminal SUMO-StrepII tag has proven effective .

• Purification protocol:

  • Implement a multi-step purification approach:
    a) Initial capture using affinity chromatography (Ni-NTA)
    b) Intermediate purification via ion-exchange chromatography
    c) Polishing step using size-exclusion chromatography

  • Maintain protein stability with optimized buffer conditions (typically 50 mM Tris-HCl pH 7.5, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT) .

• Protein quality assessment:

  • Verify purity using SDS-PAGE (>95% purity required for crystallization)

  • Confirm identity via mass spectrometry

  • Assess enzymatic activity using tRNA modification assays

  • Evaluate protein homogeneity with dynamic light scattering

What mechanisms explain the apparent differential expression of proteins in Xanthomonas oryzae pv. oryzae with mutations in tRNA modification pathways?

The differential expression of proteins in Xanthomonas oryzae pv. oryzae with mutations in tRNA modification pathways can be explained through several interconnected mechanisms:

• Codon usage bias effects: Modifications at the tRNA anticodon loop directly affect codon recognition efficiency. When tgt is mutated, tRNAs lacking queuine modification may have altered codon preference, affecting translation of proteins with specific codon usage patterns.

• Translational fidelity impact: Research with RaxST (another Xoo modification enzyme) demonstrates that post-translational modifications influence protein expression patterns. When RaxST was knocked out, 49 proteins showed differential expression (>1.5-fold difference) . Similar mechanisms likely apply to tgt mutations.

• Cellular response to stress: tRNA modification defects trigger cellular stress responses, leading to compensatory changes in protein expression. This is evident in the clusters of orthologous groups (COG) analysis of RaxST mutants, which showed changes in cell motility proteins .

• Indirect regulatory effects: tRNA modifications can influence the translation of regulatory proteins (transcription factors, two-component systems), creating cascade effects on downstream protein expression. This likely explains why approximately 7% of observed proteins were influenced by tyrosine sulfation by RaxST in Xoo .

• Structural alterations in translation machinery: Modified tRNAs interact differently with ribosomes and translation factors, potentially altering translational dynamics globally.

How can researchers distinguish between direct effects of tgt mutation and secondary adaptations in Xanthomonas oryzae pv. oryzae proteome studies?

Distinguishing between direct effects of tgt mutation and secondary adaptations in proteome studies requires sophisticated experimental design and analytical approaches:

• Time-course proteomic analysis:

  • Implement temporal sampling following conditional inactivation of tgt

  • Early changes (0-6 hours) likely represent direct effects

  • Later changes (12-48 hours) typically indicate secondary adaptations

  • Compare with temporal pattern observed in RaxST knockout studies where changes in 49 proteins were documented

• Integration of transcriptomics and proteomics:

  • Correlate protein abundance changes with mRNA levels

  • Discordance suggests post-transcriptional regulation (potential direct tgt effect)

  • Concordance indicates transcriptional regulation (likely secondary adaptation)

• Ribosome profiling:

  • Analyze ribosome occupancy on mRNAs in wildtype vs. tgt mutant

  • Altered ribosome density at specific codons indicates direct translational effects

• Polysome profiling with selective mRNA analysis:

  • Examine translation efficiency of specific mRNAs

  • Direct effects of tgt mutation would alter polysome association patterns

• Correlation with tRNA modification levels:

  • Quantify tRNA modification status using mass spectrometry

  • Direct effects should correlate with changes in specific tRNA modifications

What is the optimal protocol for assessing tgt-mediated incorporation of modified nucleobases in bacterial systems?

The optimal protocol for assessing tgt-mediated incorporation of modified nucleobases in bacterial systems involves a systematic approach combining in vitro and cellular assays:

A. In vitro tRNA-[14C] guanine displacement assay:

• Preparation of pre-charged tRNA:

  • Incubate yeast tRNA (25 absorbance units at 260 nm) with E. coli TGT (10 μg)

  • Reaction buffer: 50 mM Tris-HCl pH 7.5, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT

  • Add [14C] guanine (144 μM)

  • Incubate for 2 hours at 37°C

  • Extract tRNA using acid phenol:chloroform (5:1, pH 4.5)

  • Precipitate with sodium acetate and ethanol

• Displacement assay:

  • Combine 50 mM Tris-HCl pH 7.5, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT

  • Add 2 μg recombinant Xoo tgt enzyme

  • Add 200 μM of test substrate (guanine, queuine, or modified nucleobase)

  • Initiate reaction with radiolabeled tRNA (2 absorbance units)

  • Incubate for 1 hour at 37°C

  • Separate components using DEAE-cellulose resin

  • Quantify displaced [14C] guanine by scintillation counting

B. Cellular incorporation assay:

• Prepare bacterial culture:

  • Grow Xoo cultures to mid-log phase (OD600 = 0.4-0.6)

  • Wash cells and resuspend in fresh medium

• Incorporation of modified nucleobase:

  • Add varying concentrations of nucleobase (50-500 nM)

  • Incubate for 48-72 hours

  • Wash cells and add tritium-labeled queuine ([3H] queuine) at 25-100 nM

  • Incubate for additional 24 hours

• Analysis:

  • Harvest cells and lyse with ice-cold 30% TCA

  • Collect precipitates by vacuum filtration

  • Rinse with ice-cold 5% TCA and 95% ethanol

  • Dry and count radioactivity by scintillation counting

How can researchers distinguish between Xanthomonas oryzae pv. oryzae tgt activity and other enzymes involved in tRNA modification?

Distinguishing between Xanthomonas oryzae pv. oryzae tgt activity and other tRNA modification enzymes requires specific techniques targeting unique enzyme properties:

• Substrate specificity assays:

  • tgt specifically catalyzes the exchange of guanine for queuine or precursors at position 34

  • Compare incorporation rates using different substrates:

    • Guanine (incorporated by multiple enzymes)

    • Queuine (specific to tgt)

    • NPPDAG (artificial substrate recognized by tgt)

    • 7-methylguanine (typically not a tgt substrate)

• Enzyme inhibition profiles:

  • Employ selective inhibitors for different classes of tRNA modification enzymes

  • tgt activity is uniquely sensitive to certain competitive inhibitors

• Genetic complementation experiments:

  • Express recombinant Xoo tgt in E. coli tgt knockout strains (tgt::Kmr)

  • Restoration of specific tRNA modifications indicates functional Xoo tgt

• Mass spectrometry analysis of modified tRNAs:

  • Digest tRNAs and analyze modified nucleosides

  • Each modification enzyme generates specific nucleoside profiles

  • tgt produces G→Q modifications at position 34 of specific tRNAs

• Comparison with known modification patterns:

  • Create a reference table comparing modification profiles:

How should researchers interpret conflicting data between in vitro and in vivo tgt activity assays?

When faced with conflicting data between in vitro and in vivo tgt activity assays, researchers should follow this systematic approach to interpretation:

• Evaluate assay sensitivity and specificity:

  • In vitro displacement assays using [14C] guanine typically show maximum displacement of 240 pmol [14C] guanine with 200 μM queuine

  • Background values should be ≤10 pmol

  • Higher background may indicate experimental issues rather than true biological differences

• Consider physiological factors absent in vitro:

  • Cellular tRNA availability - in vivo, tRNAs may be sequestered by translation machinery

  • Substrate accessibility - cellular compartmentalization may limit substrate access

  • Competitor molecules - cellular metabolites may compete with substrates

  • Post-translational modifications - cellular tgt may have modifications absent in recombinant protein

• Analyze reaction conditions:

  • Buffer composition differences (in studies with RaxST, standard conditions were 50 mM Tris-HCl pH 7.5, 20 mM NaCl)

  • Temperature variations (optimal temperature for Xoo enzymes may differ from standard 37°C)

  • Cofactor availability (Mg2+ concentration typically 5 mM is critical)

  • Redox environment (DTT concentration typically 2 mM)

• Examine enzyme preparation differences:

  • Recombinant tags may affect activity (compare N-terminal polyhistidine tagged vs. C-terminal tagged versions)

  • Expression system artifacts (bacterial vs. eukaryotic expression systems)

  • Protein purity considerations (contaminants may inhibit or enhance activity)

• Integration strategies:

  • Weight evidence based on physiological relevance

  • Develop mathematical models to reconcile differences

  • Design hybrid assays bridging in vitro and in vivo conditions

What statistical approaches are most appropriate for analyzing differential protein expression in tgt mutant vs. wild-type Xanthomonas oryzae pv. oryzae strains?

The most appropriate statistical approaches for analyzing differential protein expression in tgt mutant vs. wild-type Xanthomonas oryzae pv. oryzae strains combine rigorous quantification with biological context:

• Preliminary data quality assessment:

  • Evaluate coefficient of variation (CV) in technical replicates (acceptable: <20%)

  • Assess correlation between biological replicates (R² should exceed 0.85)

  • In comparable studies with RaxST mutants, CVs of 15.88 and 16.12 were observed for PSMs in wildtype and mutant strains, respectively

• Normalization strategies:

  • Total spectral counts normalization

  • Median of ratios method

  • NSAF (Normalized Spectral Abundance Factor)

  • Machine learning-based normalization for complex datasets

• Differential expression analysis:

  • Fold change thresholds (typically >1.5-fold as used in RaxST studies)

  • Statistical significance tests:

    • Student's t-test with multiple testing correction (Benjamini-Hochberg)

    • ANOVA for multi-condition comparisons

    • Rank product test for small sample sizes

  • Volcano plot visualization (combining fold change and p-value)

• Functional enrichment analysis:

  • Gene Ontology (GO) enrichment

  • Clusters of Orthologous Groups (COG) analysis as performed in RaxST studies

  • KEGG pathway enrichment

  • Protein-protein interaction network analysis

• Example analytical workflow based on RaxST studies:

How can researchers correlate tgt activity with specific phenotypic changes in Xanthomonas oryzae pv. oryzae pathogenicity?

Correlating tgt activity with specific phenotypic changes in Xanthomonas oryzae pv. oryzae pathogenicity requires multi-level analysis connecting molecular mechanisms to organismal behaviors:

• Quantitative tgt activity measurements:

  • Develop a standardized assay to measure tgt activity in bacterial lysates

  • Establish correlation between enzyme activity and modification levels in specific tRNAs

  • Create activity gradients using partial inhibition or controlled expression

• Pathogenicity assays with activity correlation:

  • Inoculate rice plants with Xoo strains having varying tgt activity levels

  • Measure disease progression parameters:

    • Lesion length and area

    • Bacterial population density in planta

    • Time to symptom development

  • Plot pathogenicity metrics against enzyme activity to establish dose-response relationships

• Molecular phenotype assessment:

  • RNA-seq to identify transcriptional changes correlated with tgt activity

  • Proteomics to analyze differential protein expression (similar to RaxST studies where 49 proteins showed >1.5-fold difference)

  • Metabolomics to detect changes in bacterial metabolism

• Mechanistic validation:

  • Point mutations in tgt catalytic site to create activity gradients

  • Complementation with wildtype tgt to confirm phenotype rescue

  • Directed evolution to generate tgt variants with altered activity

• Integrated phenotypic network analysis:

  • Network modeling of molecular and phenotypic data

  • Identification of key nodes linking tgt activity to pathogenicity

  • Prediction and validation of interacting pathways

What are the common pitfalls in recombinant Xanthomonas oryzae pv. oryzae tgt expression and how can they be overcome?

Common pitfalls in recombinant Xanthomonas oryzae pv. oryzae tgt expression and their solutions include:

• Low expression yield:

  • Problem: Poor protein accumulation despite strong promoter

  • Diagnosis: Verify mRNA levels by RT-PCR; check for toxicity effects

  • Solutions:

    • Optimize codon usage for expression host

    • Lower induction temperature (16-20°C)

    • Use tightly regulated expression systems

    • Consider fusion partners (SUMO, MBP, thioredoxin)

    • Use E. coli BL21(DE3) tgt::Kmr cells to prevent competition with host tgt

• Protein insolubility:

  • Problem: Formation of inclusion bodies

  • Diagnosis: Analyze soluble and insoluble fractions by SDS-PAGE

  • Solutions:

    • Reduce expression rate (lower IPTG concentration, 0.1-0.5 mM)

    • Co-express with chaperones (GroEL/ES, DnaK/J)

    • Add solubility tags (N-terminal polyhistidine tags have worked well)

    • Screen multiple buffer compositions (50 mM Tris-HCl pH 7.5, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT recommended)

• Poor enzymatic activity:

  • Problem: Purified protein shows minimal activity

  • Diagnosis: Compare with activity of native enzyme from Xoo extract

  • Solutions:

    • Verify protein folding using circular dichroism

    • Ensure metal cofactor presence (Mg2+ at 5 mM)

    • Test different pH conditions (optimal typically pH 7.5)

    • Add stabilizing agents (glycerol 5-10%)

• Proteolytic degradation:

  • Problem: Multiple bands or smearing on SDS-PAGE

  • Diagnosis: Western blot with anti-His antibody; N-terminal sequencing

  • Solutions:

    • Add protease inhibitors during purification

    • Decrease purification time and temperature

    • Remove flexible linkers in fusion constructs

    • Use protease-deficient expression strains

How can researchers optimize tRNA substrate preparation for tgt activity assays?

Optimizing tRNA substrate preparation for tgt activity assays requires attention to several critical factors:

• Source selection:

  • Commercial yeast tRNA is commonly used for initial studies

  • For species-specific analysis, prepare tRNA from Xoo cultures

  • In vitro transcribed tRNA provides defined substrates but lacks natural modifications

• Purification methods:

  • Total tRNA extraction protocol:

    • Lyse cells in buffer containing 50 mM Tris-HCl pH 7.5, 10 mM MgCl2

    • Extract with acid phenol:chloroform (5:1, pH 4.5)

    • Precipitate with sodium acetate (0.1 volume of 3 M) and ethanol (2 volumes)

    • Wash with 70% ethanol and redissolve in nuclease-free water

  • Specific tRNA isolation:

    • Use biotinylated oligonucleotides complementary to target tRNA

    • Capture with streptavidin-coated magnetic beads

    • Elute with heating or competing oligonucleotides

• Quality control measures:

  • Purity assessment:

    • A260/A280 ratio (should be ~2.0 for pure tRNA)

    • Denaturing PAGE (should show discrete bands)

  • Functionality testing:

    • Aminoacylation assay with cognate aminoacyl-tRNA synthetase

    • Pre-modification with E. coli TGT to prepare radiolabeled substrate

• Pre-charging with [14C] guanine:

  • Optimized reaction conditions:

    • 50 mM Tris-HCl pH 7.5, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT

    • 25 absorbance units (260 nm) of tRNA

    • 144 μM [14C] guanine

    • 10 μg E. coli TGT enzyme

    • Incubate for 2 hours at 37°C

  • Purification of charged tRNA:

    • Extract with acid phenol:chloroform

    • Precipitate with sodium acetate and ethanol

    • Redissolve in nuclease-free water

• Storage and stability:

  • Store tRNA at -80°C in small aliquots

  • Add RNase inhibitors for long-term storage

  • Avoid freeze-thaw cycles

  • Validate activity periodically with control reactions

What are the key considerations for transitioning from in vitro to in vivo studies of tgt function in Xanthomonas oryzae pv. oryzae?

Transitioning from in vitro to in vivo studies of tgt function in Xanthomonas oryzae pv. oryzae requires careful consideration of multiple factors:

• Genetic manipulation strategies:

  • Gene knockout approach:

    • Homologous recombination with suicide vectors

    • CRISPR-Cas9 mutagenesis for precise gene editing

    • Considerations similar to RaxST knockout studies where phenotypic changes were observed

  • Conditional expression systems:

    • Inducible promoters (tetracycline-responsive)

    • Temperature-sensitive variants

    • Degron-tagged versions for controlled degradation

• Phenotypic assessment framework:

  • Growth characteristics:

    • Growth curves in various media

    • Stress response profiling (pH, temperature, oxidative stress)

    • Nutrient utilization patterns

  • Virulence assays:

    • Rice leaf inoculation

    • Lesion measurement and bacterial quantification

    • Comparison with RaxST studies where twitching motility was affected

• Molecular readouts:

  • tRNA modification analysis:

    • LC-MS/MS of nucleosides from total tRNA

    • Northern blotting with modification-specific probes

    • [3H] queuine incorporation assays for cellular uptake

  • Global impact assessment:

    • RNA-seq for transcriptome analysis

    • Proteomics for protein expression changes (expect ~7% of proteome to be affected, based on RaxST studies)

    • Ribosome profiling for translation effects

• Validation strategies:

  • Complementation testing:

    • Reintroduction of wildtype gene

    • Site-directed mutants with altered activity

    • Heterologous tgt expression

  • Chemical complementation:

    • Supplementation with queuine or precursors

    • Use of NPPDAG or other artificial substrates

    • Dose-response analysis

• Integration with host response:

  • Immune activation assessment:

    • Monitor rice XA21-mediated immunity responses

    • Analyze plant transcriptional changes

    • Compare with findings from RaxST studies where immunity activation was observed

What emerging technologies could enhance our understanding of tgt function in Xanthomonas oryzae pv. oryzae?

Several emerging technologies hold promise for advancing our understanding of tgt function in Xanthomonas oryzae pv. oryzae:

• Advanced imaging techniques:

  • Super-resolution microscopy:

    • Track tgt localization in live bacteria

    • Visualize interactions with tRNA and other cellular components

    • Correlate with bacterial motility observations seen in related RaxST studies

  • Cryo-electron microscopy:

    • Determine high-resolution structures of Xoo tgt

    • Analyze conformational changes during catalysis

    • Compare with structures of other bacterial phytochrome-like proteins in Xoo like XoBphP

• Novel sequencing approaches:

  • Nanopore direct RNA sequencing:

    • Direct detection of tRNA modifications without nucleoside digestion

    • Single-molecule resolution of modification patterns

    • Real-time monitoring of modification dynamics

  • Ribosome profiling with modification-specific analysis:

    • Correlate tRNA modifications with translation rates

    • Identify codon-specific translation effects

    • Link to proteomic changes observed in similar studies

• Chemical biology tools:

  • Click chemistry-compatible queuine analogs:

    • Track queuine incorporation in cellular tRNAs

    • Identify proteins interacting with modified tRNAs

    • Build on findings from NPPDAG incorporation studies

  • CRISPR-based screens:

    • Genome-wide identification of genetic interactions with tgt

    • Discovery of synthetic lethality partners

    • Validation of hypothesized pathways

• Computational approaches:

  • Machine learning for modification prediction:

    • Develop algorithms to predict modification sites

    • Integrate multiple data types (sequence, structure, function)

    • Create predictive models of modification impact

  • Molecular dynamics simulations:

    • Model tgt-tRNA interactions at atomic resolution

    • Predict effects of mutations or substrate variations

    • Integrate with experimental validation

How might comparative studies between different Xanthomonas species enhance our understanding of tgt evolution and function?

Comparative studies between different Xanthomonas species can provide significant insights into tgt evolution and function through multiple approaches:

• Phylogenomic analysis:

  • Evolutionary trajectory mapping:

    • Reconstruct tgt gene history across Xanthomonas species

    • Identify selective pressures and conservation patterns

    • Compare with other tRNA modification enzymes

  • Host adaptation signatures:

    • Correlate tgt sequence variations with host range

    • Identify host-specific adaptations

    • Compare with phytochrome-like proteins like XoBphP that show species-specific features

• Structure-function comparisons:

  • Catalytic domain conservation:

    • Analyze conservation of key residues across species

    • Map variations to structural elements

    • Identify species-specific insertions or deletions

  • Substrate specificity determinants:

    • Compare substrate preferences across species

    • Identify residues conferring specificity

    • Engineer chimeric enzymes to validate predictions

• Regulatory network integration:

  • Promoter architecture analysis:

    • Compare tgt expression control elements

    • Identify shared regulatory motifs

    • Correlate with expression patterns

  • Regulatory protein interactions:

    • Map species-specific protein-protein interactions

    • Identify conserved regulatory partners

    • Compare with other modification systems like RaxST

• Pathogenicity correlation studies:

  • Host range and tgt variation:

    • Compare tgt sequences with host specificity

    • Identify pathogenicity-associated variations

    • Test through cross-species complementation

  • Virulence mechanism integration:

    • Analyze co-evolution with other virulence factors

    • Compare with systems like RaxST that influence XA21-mediated immunity

    • Develop integrated models of pathogenicity

• Experimental cross-species validation:

  • Heterologous expression:

    • Express tgt from different species in model organisms

    • Compare activity and specificity

    • Identify functional innovations

  • Chimeric enzyme analysis:

    • Create domain-swapped versions between species

    • Map functional domains to phenotypic effects

    • Develop evolutionary trajectory models